MELBOURNE, Australia--(BUSINESS WIRE)--March 21, 2006--Norwood Abbey Ltd (ASX:NAL) through its subsidiary Norwood Immunology Ltd (AIM:NIM), has announced the signing of a tripartite research agreement with the Australian Stem Cell Centre (ASCC) and Monash University, to form an important new technology platform combining immune system research with stem cell know-how. The new research technology has the potential to add significant value to Norwood Immunology's Intellectual Property pipeline.
